| 5NT | 5′-ectonucleotidase |
| ALP | alkaline phosphatase |
| AMPK | AMP-activated protein kinase |
| BMD | bone mineral density |
| BMP | bone morphogenic protein |
| BNIP3 | BCL2-Interacting protein 3 |
| CKD CPP |
chronic kidney disease calciprotein particle |
| CVD | cardiovascular disease |
| Drp1 | dynamin related protein 1 |
| ECM EMT |
extracellular matrix epithelial-to-mesenchymal transition |
| ENPP1 | ecto-nucleotid pyrophosphatases/phosphodiesterase 1 |
| ENT1 | nucleotide transporter 1 |
| ER | endoplasmic reticulum |
| Fet-A | fetuin-A |
| FGF23 | fibroblast growth factor 23 |
| HIF-1α | hypoxia-inducible factor 1 alpha |
| Mfn | mitofusin |
| MGP | matrix gla protein |
| MSX2 | Msh Homeobox 2 |
| mPTP | mitochondrial permeability transition pore |
| mTOR | mammalian target of rapamycin |
| NF-κB | nuclear factor-kappa B |
| Nrf2 | nuclear factor erythroid 2-related factor 2 |
| OC | osteocalcin |
| O-GlcNAcylation | O-linked N-acetylglucosamine |
| Opa1 | optic dominant atrophy 1 |
| OPG | osteoprotegerin |
| OPN | osteopontin |
| PDC | pyruvate dehydrogenase complex |
| PDK | pyruvate dehydrogenase kinase |
| PTH | parathyroid hormone |
| PDGF | platelet-derived growth factor |
| Pi | inorganic phosphate |
| PPi | pyrophosphate |
| PDK | pyruvate dehydrogenase kinase |
| RANK | receptor activator of nuclear factor-kappa B |
| RANKL | RANK ligand |
| Runx2 | runt-related transcription factor 2 |
| ROS | reactive oxygen species |
| SGK1 | serum- and glucocorticoid-inducible kinase 1 |
| SMA | α-smooth-muscle actin |
| SMCs | smooth muscle cells |
| SMPD3 | sphingomyelin phosphodiesterase 3 |
| TNAP | tissue non-specific alkaline phosphatase |
| TNF-α | tumor necrosis factor alpha |
| TRPC3 | transient receptor potential canonical 3 |
| VC | vascular calcification |
| VSMC | vascular smooth muscle cell |
| UPR | unfolded protein response |